These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Colossolactone-G synergizes the anticancer properties of 5-fluorouracil and gemcitabine against colorectal cancer cells. Algehani RA; Abou Khouzam R; Hegazy GA; Alamoudi AA; El-Halawany AM; El Dine RS; Ajabnoor GA; Al-Abbasi FA; Baghdadi MA; Elsayed I; Hattori M; Al-Abd AM Biomed Pharmacother; 2021 Aug; 140():111730. PubMed ID: 34062410 [TBL] [Abstract][Full Text] [Related]
4. Synergistic combination of gemcitabine and dietary molecule induces apoptosis in pancreatic cancer cells and down regulates PKM2 expression. Pandita A; Kumar B; Manvati S; Vaishnavi S; Singh SK; Bamezai RN PLoS One; 2014; 9(9):e107154. PubMed ID: 25197966 [TBL] [Abstract][Full Text] [Related]
5. Thymoquinone induces cell death in human squamous carcinoma cells via caspase activation-dependent apoptosis and LC3-II activation-dependent autophagy. Chu SC; Hsieh YS; Yu CC; Lai YY; Chen PN PLoS One; 2014; 9(7):e101579. PubMed ID: 25000169 [TBL] [Abstract][Full Text] [Related]
6. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Arafa el-SA; Zhu Q; Shah ZI; Wani G; Barakat BM; Racoma I; El-Mahdy MA; Wani AA Mutat Res; 2011 Jan; 706(1-2):28-35. PubMed ID: 21040738 [TBL] [Abstract][Full Text] [Related]
7. Thymoquinone Augments Cyclophosphamide-Mediated Inhibition of Cell Proliferation in Breast Cancer Cells. Khan A; Aldebasi YH; Alsuhaibani SA; Khan MA Asian Pac J Cancer Prev; 2019 Apr; 20(4):1153-1160. PubMed ID: 31030489 [TBL] [Abstract][Full Text] [Related]
8. Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer. Banerjee S; Azmi AS; Padhye S; Singh MW; Baruah JB; Philip PA; Sarkar FH; Mohammad RM Pharm Res; 2010 Jun; 27(6):1146-58. PubMed ID: 20422266 [TBL] [Abstract][Full Text] [Related]
9. Reverse Screening Bioinformatics Approach to Identify Potential Anti Breast Cancer Targets Using Thymoquinone from Neutraceuticals Black Cumin Oil. Sundaravadivelu S; Raj SK; Kumar BS; Arumugamand P; Ragunathan PP Anticancer Agents Med Chem; 2019; 19(5):599-609. PubMed ID: 30678630 [TBL] [Abstract][Full Text] [Related]
10. Combinatorial therapy of Thymoquinone and Emodin synergistically enhances apoptosis, attenuates cell migration and reduces stemness efficiently in breast cancer. Bhattacharjee M; Upadhyay P; Sarker S; Basu A; Das S; Ghosh A; Ghosh S; Adhikary A Biochim Biophys Acta Gen Subj; 2020 Nov; 1864(11):129695. PubMed ID: 32735937 [TBL] [Abstract][Full Text] [Related]
11. Low Doses of Thymoquinone and Ferulic Acid in Combination Effectively Inhibit Proliferation of Cultured MDA-MB 231 Breast Adenocarcinoma Cells. Al-Mutairi A; Rahman A; Rao MS Nutr Cancer; 2021; 73(2):282-289. PubMed ID: 32223348 [TBL] [Abstract][Full Text] [Related]
12. Effects of 5-fluorouracil, thymoquinone, and mammary stem cells' exosomes on Abdelfattah-Hassan A; Ibrahim D; Saleh AA; Kishawy ATY; Mohamed RHA; Khater SI Open Vet J; 2024 Jan; 14(1):525-533. PubMed ID: 38633189 [TBL] [Abstract][Full Text] [Related]
13. Radiosensitization in human breast carcinoma cells by thymoquinone: role of cell cycle and apoptosis. Velho-Pereira R; Kumar A; Pandey BN; Jagtap AG; Mishra KP Cell Biol Int; 2011 Oct; 35(10):1025-9. PubMed ID: 21557727 [TBL] [Abstract][Full Text] [Related]
14. Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS. Woo CC; Hsu A; Kumar AP; Sethi G; Tan KH PLoS One; 2013; 8(10):e75356. PubMed ID: 24098377 [TBL] [Abstract][Full Text] [Related]
15. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells. Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of ERα/ERK/P62 cascades induces "autophagic switch" in the estrogen receptor-positive breast cancer cells exposed to gemcitabine. Shen P; Chen M; He M; Chen L; Song Y; Xiao P; Wan X; Dai F; Pan T; Wang Q Oncotarget; 2016 Jul; 7(30):48501-48516. PubMed ID: 27384485 [TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of thymoquinone and melatonin against breast cancer implanted in mice. Odeh LH; Talib WH; Basheti IA J Cancer Res Ther; 2018 Jun; 14(Supplement):S324-S330. PubMed ID: 29970684 [TBL] [Abstract][Full Text] [Related]
18. Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K/Akt/mTOR Regulated Signaling Pathways in Pancreatic Cancer. Mu GG; Zhang LL; Li HY; Liao Y; Yu HG Dig Dis Sci; 2015 Apr; 60(4):1067-80. PubMed ID: 25344906 [TBL] [Abstract][Full Text] [Related]
19. Innovative approach against cancer: Thymoquinone-loaded PHEMA-based magnetic nanoparticles and their effects on MCF-7 breast cancer. Yıldırım M; Acet Ö; Önal Acet B; Karakoç V; Odabaşı M Biochem Biophys Res Commun; 2024 Nov; 734():150464. PubMed ID: 39083970 [TBL] [Abstract][Full Text] [Related]
20. Sulforaphane inhibits growth of human breast cancer cells and augments the therapeutic index of the chemotherapeutic drug, gemcitabine. Hussain A; Mohsin J; Prabhu SA; Begum S; Nusri Qel-A; Harish G; Javed E; Khan MA; Sharma C Asian Pac J Cancer Prev; 2013; 14(10):5855-60. PubMed ID: 24289589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]